Reproductive Health

HANX Expands into Weight Management with GLP-1 Medications

HANX, the UK-based sexual wellness and intimate care brand, has announced a significant expansion of its digital pharmacy services with the introduction of GLP-1 medications, marking its evolution into the broader femtech category. The new weight management offering is designed to support women struggling with conditions like Polycystic Ovary Syndrome (PCOS), endometriosis, and menopause. The GLP-1 medications, Mounjaro (tirzepatide) and Wegovy (semaglutide),…

Tennis Legend Maria Sharapova Joins Cofertility as Investor to Expand Access to Egg Freezing and Donation

Tennis legend Maria Sharapova has joined Cofertility as their newest investor, bringing her influence and financial backing to the startup. Cofertility aims to make egg freezing more accessible and affordable by linking it with egg donation, offering women the opportunity to freeze their eggs for free when they donate half to intended parents who are unable to conceive. Sharapova, who retired from…

Aetna Expands Fertility Coverage, Making Intrauterine Insemination (IUI) More Accessible

Aetna, a CVS Health company, is now the first major insurer in the US to include intrauterine insemination (IUI) as a covered medical benefit for all eligible plans. This new coverage will be available beginning September 1, 2024, and aims to increase access to fertility services for a broader range of individuals, regardless of sexual orientation or partner status. Previously, coverage for…

Alife Health Study Highlights Potential of AI in Enhancing IVF Ovarian Stimulation Decisions

Alife Health, a fertility technology company focused on modernizing in vitro fertilization (IVF) through AI, has revealed promising findings from a study that explores the role of artificial intelligence in optimizing ovarian stimulation during IVF treatment. The study, titled “Optimizing Oocyte Yield Utilizing a Machine Learning Model for Dose and Trigger Decisions: A Multi-Center, Prospective Study,” was conducted by a team of…

Clue and Headspace Collaborate to Support Menstruator Mental Health

Reproductive health app Clue has partnered with mental health platform Headspace to provide tailored support for women and people with cycles navigating mental health challenges linked to their menstrual health. Through this collaboration, Clue Plus members will have access to a 50% discount on a Headspace subscription, offering resources designed to help manage cycle-related stress and enhance overall well-being. This partnership addresses…

Fibra Raises $1.25M in Pre-Seed Round to Advance Fertility Tracking Underwear

Toronto-based startup Fibra has closed its oversubscribed pre-seed funding round, raising $1.25 million USD ($1.7 million CAD). The funding will be used to accelerate the development of Fibra’s smart underwear technology designed to ease reproductive health monitoring for women. The round saw participation from Canadian and U.S.-based venture capital firms, reflecting growing investor confidence in innovations focused on women’s health. “We are…

Motherbeing Launches Daleela, an AI-Powered Health Assistant Designed for Arab Women

Motherbeing, an Egypt-based femtech company, has launched a new mobile app called Daleela, designed to use AI technology to provide Arab women with secure, private access to information and personalized support related to their sexual and reproductive health. Available on both iOS and Android, Daleela offers a platform where women can engage with an AI assistant to receive tailored advice on topics…

Quest Diagnostics Study Reveals Pregnant Women Are Undertested for STIs, Raising Concerns for Maternal and Newborn Health

A new study conducted by Quest Diagnostics in collaboration with the University of Alabama has revealed significant gaps in the testing and treatment of sexually transmitted infections (STIs) among pregnant women in the United States. The study, titled Chlamydia and gonorrhea testing in pregnancy: Time to improve adherence and update recommendations, was published in the ‘Journal of Lower Genital Tract Disease’ and…